EP1210182A1 - Permeabilisation de biofilms - Google Patents

Permeabilisation de biofilms

Info

Publication number
EP1210182A1
EP1210182A1 EP00946762A EP00946762A EP1210182A1 EP 1210182 A1 EP1210182 A1 EP 1210182A1 EP 00946762 A EP00946762 A EP 00946762A EP 00946762 A EP00946762 A EP 00946762A EP 1210182 A1 EP1210182 A1 EP 1210182A1
Authority
EP
European Patent Office
Prior art keywords
biofilm
target material
stress
compound
biofilms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00946762A
Other languages
German (de)
English (en)
Inventor
Nikolaos S. Soukos
Shun Lee
Apostolos G. Doukas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP1210182A1 publication Critical patent/EP1210182A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

L'invention concerne des procédés de perméabilisation de biofilms faisant appel à des ondes de contrainte et consistant à appliquer une ou plusieurs ondes de contrainte sur un biofilm, par exemple sur une surface d'un dispositif ou d'un produit alimentaire, ou encore sur une surface tissulaire d'un patient, puis à induire des ondes de contrainte pour provoquer des augmentations transitoires de la perméabilité du biofilm. Cette amélioration de la perméabilité facilite la distribution de composés, notamment des agents antimicrobiens ou thérapeutiques dans et à travers le biofilm.
EP00946762A 1999-05-12 2000-05-12 Permeabilisation de biofilms Withdrawn EP1210182A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13373099P 1999-05-12 1999-05-12
US133730P 1999-05-12
PCT/US2000/013231 WO2000067917A1 (fr) 1999-05-12 2000-05-12 Permeabilisation de biofilms

Publications (1)

Publication Number Publication Date
EP1210182A1 true EP1210182A1 (fr) 2002-06-05

Family

ID=22460051

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00946762A Withdrawn EP1210182A1 (fr) 1999-05-12 2000-05-12 Permeabilisation de biofilms

Country Status (4)

Country Link
EP (1) EP1210182A1 (fr)
JP (1) JP2003534235A (fr)
CA (1) CA2373447A1 (fr)
WO (1) WO2000067917A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
EP1613202B1 (fr) 2003-03-27 2011-02-09 The General Hospital Corporation Appareil de traitement dermatologique et de restructuration fractionnelle de surface cutanee
US7413572B2 (en) 2004-06-14 2008-08-19 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
JP4500206B2 (ja) * 2005-05-09 2010-07-14 株式会社三栄水栓製作所 バイオフィルム評価方法
AU2008274906B2 (en) 2007-07-12 2013-11-07 Oral Health Australia Pty Ltd Biofilm treatment
EP3255057B1 (fr) 2008-08-29 2020-03-18 Oral Health Australia Pty Ltd Prévention, traitement et diagnostic de l'infection à p. gingivalis
US8679103B2 (en) 2008-12-22 2014-03-25 Valam Corporation Two step mammalian biofilm treatment processes and systems
CN103417546B (zh) * 2013-08-19 2016-01-27 中国人民解放军军事医学科学院基础医学研究所 亚甲蓝的一种麻醉后促清醒的用途
KR102087187B1 (ko) * 2013-12-03 2020-03-11 (주)아모레퍼시픽 피부 개선용 키트

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5421816A (en) * 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US5458140A (en) * 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US5618275A (en) * 1995-10-27 1997-04-08 Sonex International Corporation Ultrasonic method and apparatus for cosmetic and dermatological applications
US6009346A (en) * 1998-01-02 1999-12-28 Electromagnetic Bracing Systems, Inc. Automated transdermal drug delivery system
US6030374A (en) * 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0067917A1 *

Also Published As

Publication number Publication date
WO2000067917A1 (fr) 2000-11-16
JP2003534235A (ja) 2003-11-18
CA2373447A1 (fr) 2000-11-16

Similar Documents

Publication Publication Date Title
Al Shahrani et al. Enhanced removal of Enterococcus faecalis biofilms in the root canal using sodium hypochlorite plus photon-induced photoacoustic streaming: an in vitro study
Grzech-Leśniak et al. Laser reduction of specific microorganisms in the periodontal pocket using Er: YAG and Nd: YAG lasers: a randomized controlled clinical study
GUTKNECHT et al. Diode laser radiation and its bactericidal effect in root canal wall dentin
Pedullà et al. Decontamination efficacy of photon‐initiated photoacoustic streaming (PIPS) of irrigants using low‐energy laser settings: an ex vivo study
Sarda et al. Antimicrobial efficacy of photodynamic therapy, diode laser, and sodium hypochlorite and their combinations on endodontic pathogens
US6689094B2 (en) Compound delivery using impulse transients
Bevilacqua et al. The impact of photodynamic therapy on the viability of Streptococcus mutans in a planktonic culture
JP2008507327A (ja) 歯科的用途のための音響光力学的治療
Betancourt et al. Effectiveness of low concentration of sodium hypochlorite activated by Er, Cr: YSGG laser against Enterococcus faecalis biofilm
Zand et al. Antimicrobial efficacy of photodynamic therapy and sodium hypochlorite on monoculture biofilms of Enterococcus faecalis at different stages of development
US20090054881A1 (en) Mammalian biofilm treatment processes and instruments
WO2000067917A1 (fr) Permeabilisation de biofilms
Liu et al. Bacterial-killing effect of atmospheric pressure non-equilibrium plasma jet and oral mucosa response
JP2016520623A (ja) 活性成分を光活性化することを含む、組成物を適用する方法および投与されるレジメンを有する医薬組成物
Xu et al. Minimization of treatment time for in vitro 1.1 MHz destruction of Pseudomonas aeruginosa biofilms by high-intensity focused ultrasound
Carvalho et al. Analysis of Aloe vera cytotoxicity and genotoxicity associated with endodontic medication and laser photobiomodulation
Tokuc et al. Bactericidal effect of 2780 nm Er, Cr: YSGG laser combined with 940 nm diode laser in Enterococcus faecalis elimination: a comparative study
US7332200B1 (en) Permeabilizing biofilms
Miranda et al. Novel technologies to improve the treatment of endodontic microbial infections: Inputs from a drug delivery perspective
Vezzani et al. Disinfection of root canals using Er: YAG laser at different frequencies
Ogura et al. Photomechanical wave-assisted molecular delivery in oral biofilms
Prabakharan et al. Proteus mirabilis viability after lithotripsy of struvite calculi
Soukos et al. Permeabilizing biofilms
Anil et al. Antimicrobial efficacy and topographical alterations of photodynamic therapy versus conventional antimicrobials on contaminated zirconia ceramic in vitro
Žekonis et al. Clinical and microbiological effects of weekly supragingival irrigation with aerosolized 0.5% hydrogen peroxide and formation of cavitation bubbles in gingival tissues after this irrigation: A six-month randomized clinical trial

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071201